CA2504796A1 - Formes polymorphes du sel sodique du pantoprazole et procede pour leur preparation - Google Patents

Formes polymorphes du sel sodique du pantoprazole et procede pour leur preparation Download PDF

Info

Publication number
CA2504796A1
CA2504796A1 CA002504796A CA2504796A CA2504796A1 CA 2504796 A1 CA2504796 A1 CA 2504796A1 CA 002504796 A CA002504796 A CA 002504796A CA 2504796 A CA2504796 A CA 2504796A CA 2504796 A1 CA2504796 A1 CA 2504796A1
Authority
CA
Canada
Prior art keywords
pantoprazole sodium
monohydrate
crystalline form
approximately
monosolvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002504796A
Other languages
English (en)
Inventor
Pietro Allegrini
Gianpiero Ventimiglia
Graziano Castaldi
Antonio Sommei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dipharma SpA
Original Assignee
Dipharma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma SpA filed Critical Dipharma SpA
Publication of CA2504796A1 publication Critical patent/CA2504796A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002504796A 2004-04-23 2005-04-21 Formes polymorphes du sel sodique du pantoprazole et procede pour leur preparation Abandoned CA2504796A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2004A000802 2004-04-23
IT000802A ITMI20040802A1 (it) 2004-04-23 2004-04-23 Polimorfi di pantoprazolo sale sodico e procedimento per la loro preparazione

Publications (1)

Publication Number Publication Date
CA2504796A1 true CA2504796A1 (fr) 2005-10-23

Family

ID=34935085

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002504796A Abandoned CA2504796A1 (fr) 2004-04-23 2005-04-21 Formes polymorphes du sel sodique du pantoprazole et procede pour leur preparation

Country Status (5)

Country Link
US (1) US20050245578A1 (fr)
EP (1) EP1598347A1 (fr)
JP (1) JP2005306874A (fr)
CA (1) CA2504796A1 (fr)
IT (1) ITMI20040802A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7507829B2 (en) * 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
CN102584790B (zh) * 2011-12-31 2014-04-02 江苏奥赛康药业股份有限公司 一种s－泮托拉唑钠三水合物及其制备和应用
CN105111189B (zh) * 2015-08-27 2017-09-22 天津大学 一种泮托拉唑钠化合物一水合物球形晶体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3926936B2 (ja) * 1998-11-16 2007-06-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホキシド誘導体・アセトン錯体およびその製造法
US6933389B2 (en) * 2002-09-02 2005-08-23 Dr. Reddy's Laboratories Limited Process for preparation of crystalline form-1 of pantoprazole sodium sesquihydrate
US7507829B2 (en) * 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
CN1791406A (zh) * 2003-05-19 2006-06-21 普利瓦研究与发展有限公司 5－(二氟甲氧基)－2－[[(3,4－二甲氧基－2－吡啶基)甲基]亚硫酰基]－1h－苯并咪唑(泮托拉唑)钠水络合物的固态形式

Also Published As

Publication number Publication date
ITMI20040802A1 (it) 2004-07-23
US20050245578A1 (en) 2005-11-03
JP2005306874A (ja) 2005-11-04
EP1598347A1 (fr) 2005-11-23

Similar Documents

Publication Publication Date Title
TWI418553B (zh) ３－〔（２－｛〔４－（己氧基羰基胺基－亞胺基－甲基）－苯胺基〕－甲基｝－１－甲基－１ｈ－苯并咪唑－５－羰基）－吡啶－２－基－胺基〕－丙酸乙酯－甲磺酸鹽及其作為藥物之用途
US20040010151A1 (en) Lansoprazole polymorphs and processes for preparation thereof
RU2385325C2 (ru) Способ получения сульфата атазанавира
JP2010521477A (ja) イマチニブメシレート
EP2907812B1 (fr) Procédé de préparation d'une forme amorphe du dexlansoprazole
US20060135565A1 (en) Crystalline form of rabeprazole sodium
JP2001039975A (ja) スルホキシド誘導体の結晶およびその製造法
JP2007145872A (ja) ランソプラゾール安定化方法
CA2504796A1 (fr) Formes polymorphes du sel sodique du pantoprazole et procede pour leur preparation
US8143409B2 (en) Crystalline form of rabeprazole sodium
US7683080B2 (en) Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
WO2022177927A1 (fr) Forme cristalline non hydratée de sel de dihydrobromure d'omecamtiv mecarbil
IL298629A (en) Methods and dosage forms for osmotic administration of pharmaceutical preparations containing deuterobenzene
US9034904B2 (en) Forms of dexlansoprazole and processes for the preparation thereof
US20060122233A1 (en) Rabeprazole calcium
SK13582001A3 (sk) Spôsob prípravy kyseliny 3S-3-amino-3-arylpropiónovej a jej derivátov
EP1743893A1 (fr) Lansoprazole stable contenant plus de 500 parties par million, jusqu'à environ 3000 parties par million d'eau et plus de 200 parties par million, jusqu'à environ 5000 parties par million d'alcool

Legal Events

Date Code Title Description
FZDE Discontinued